The tech share extends losses today.
The post Why has the Mesoblast share price crashed 40% since April? appeared first on The Motley Fool Australia. –
The Mesoblast Limited (ASX: MSB) share price has started the day well and is now trading around 4% higher at 68.5 cents apiece.
Despite the gain today, Mesoblast shares have struggled since April. They are down around 40% since that time, in continuation of a longer-term downtrend.
Mesoblast is also down 51% this year to date, amid a heavy sell-off in ASX tech shares. In the last 2 weeks, a plunge in the broader market has pulled the share lower.
What’s up with the Mesoblast share price?
Investors have been selling the Mesoblast share price down on no news. The company did release its financial and operational highlights for the last quarter on 1 June, however, the market was unfazed.
In fact, shares have been trending south for over 1 year now, having fallen hard from a sharp peak of $4.60 in December 2020.
Since then, shares have rolled lower and now trade at both 2-year and 52-week lows.
With the trend in place, there’s been no support from the market, not in 2022 anyway. The S&P/ASX All TechnologyÂ Index (ASX: XJO) is also at yearly lows having sunk 38% this year to date.
Furthermore, Mesoblast has seen proceedings started against it in a Federal Court of Australia back in May.
According to TMF at the time, the claimant â someone who bought shares between 2018-2020 â alleges Mesoblast “engaged in unlawful conduct that misled the market about remestemcel-L”.
“Mesoblast has reportedly faced multiple class actions in the US on similar allegations,” TMF added.
Nevertheless, the Mesoblast share price has tumbled more than 69% into the red over the last 12 months, as seen below.
The post Why has the Mesoblast share price crashed 40% since April? appeared first on The Motley Fool Australia.
Before you consider Mesoblast Limited, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Mesoblast Limited wasn’t one of them.
The online investing service heâs run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
See The 5 Stocks
*Returns as of January 13th 2022
setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.